Multiple myeloma is a type of blood cancer that forms in plasma cells, white blood cells that produce infection-fighting antibodies. Multiple myeloma is not hereditary, meaning it is not passed ...

Saad Usmani, Chief of MSK's Myeloma Service, says there are far more treatment options for multiple myeloma today compared with just 20 years ago. Note: This story was originally published in 2022 and ...

Linvoseltamab is an investigational B-cell maturation antigen CD3-targeted bispecific antibody. The BLA resubmission was needed as the original application could not be approved due to manufacturing ...

First Lady Louise ''Liza'' Araneta-Marcos has inspected the Coconut Palace and the Philippine International Convention Center in preparation for ASEAN 2026. The Philippines will be the chairman of the ...

Pomalyst (pomalidomide) is a prescription drug that’s used to treat multiple myeloma in adults. Pomalyst is also available as a generic drug. Pomalyst comes as an oral capsule. The active ...

its side effects After a diagnosis of multiple myeloma, the first type of treatment you receive — also called “upfront” or “front-line” therapy — now includes a promising new option. Research has ...